Environmental Impact Statements notice announces availability of assessments for proposed federal projects affecting small business operations and land use.
EPA approves Oklahoma's State Implementation Plan revisions for New Source Review permitting and general provisions submitted between 2002 and 2025 under the Federal Clean Air Act.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
The U.S. Department of Commerce is automatically initiating five-year reviews of existing antidumping and countervailing duty orders and suspended investigations under the Tariff Act of 1930.
EPA Innovation Challenge seeks public input on cost-effective alternatives to conventional pesticide desiccants for crop desiccation to inform challenge design and eligibility criteria.
EPA's Clean Air Scientific Advisory Committee holds a public meeting to review the National Ambient Air Quality Standards process and upcoming regulatory documents affecting air quality compliance.
EPA approves Delaware's second 10-year limited maintenance plan for fine particulate matter in the New Castle County portion of the Philadelphia-Wilmington nonattainment area.
EPA proposes approval of Alabama's April 7, 2026 State Implementation Plan revision updating transportation conformity procedures for interagency consultation, conflict resolution, and public participation requirements.
NMFS issued an incidental harassment authorization to the U.S. Fish and Wildlife Service for taking marine mammals incidental to research, monitoring, and management activities on the South Farallon Islands, California.
National Cancer Institute offers licensing opportunities for Chimeric VLP Vaccines to Prevent HTLV-1 Infection to research and commercialization partners.
National Cancer Institute offers licensing opportunities for a conserved viral peptide therapeutic candidate for hepatocellular carcinoma prevention and treatment through research co-development partnerships.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
